Cleary Gottlieb represented Levi Strauss & Co. in the transaction. Authentic Brands Group (Authentic) announced the acquisition of Dockers brand, from Levi Strauss & Co. (LS&Co.),...
Authentic Brands Group’s $391 Million Acquisition of Dockers Brand
T-Mobile’s $175 Million Acquisition of Blis
Cleary Gottlieb Steen & Hamilton represented T-Mobile US Inc., while DLA Piper represented Blis in the transaction. T-Mobile US Inc. (T-Mobile) announced its acquisition of Blis...
Apogee Enterprises’ $240 Million Acquisition of UW Interco
Cleary Gottlieb is representing Apogee Enterprises on the deal. Apogee Enterprises, Inc. (Apogee) signed its definitive agreement to acquire UW Interco, LLC (UW Solutions), a Heartwood...
T-Mobile’s Acquisition of UScellular’s Wireless Operations and Select Spectrum Assets
Cleary Gottlieb Steen & Hamilton and DLA Piper represented T-Mobile US Inc., Cravath, Swaine & Moore represented the independent directors of UScellular, Sidley Austin represented majority...
Rocket Software’s $2.275 Billion Acquisition of OpenText’s Application Modernization and Connectivity Business
Kirkland & Ellis is advising Rocket Software, Inc. on the transaction, and Cleary Gottlieb Steen & Hamilton is advising OpenText. Open Text Corporation (NASDAQ: OTEX), (TSX: OTEX),...
iNRCORE’s Recapitalization with Warburg Pincus and TJC
Kirkland & Ellis is advising TJC and iNRCORE on the deal, and Covington & Burling and Cleary Gottlieb Steen & Hamilton are advising Warburg Pincus. iNRCORE,...
Mitsui’s Acquisition of Industrial Pesquera Santa Priscila
Cleary Gottlieb represented Mitsui & Co., Ltd. in the transaction. Mitsui & Co., Ltd. (“Mitsui”) announced its acquisition of an investment, through a holding company, in...
Advent and Warburg Pincus’ Acquisition of BioPharma Solutions from Baxter
Cleary Gottlieb Steen & Hamilton and Ropes & Gray are serving as legal advisor to Advent and Warburg Pincus, while Sullivan & Cromwell is serving as...
Takeda’s Acquisition of NDI-034858 from Nimbus Therapeutics
Cleary Gottlieb represented Takeda in the transaction while Goodwin Procter advised Nimbus Therapeutics. Takeda (TSE:4502/NYSE:TAK) announced that it will acquire NDI-034858 from Nimbus Therapeutics. NDI-034858 is...